Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds
-
Huub H. van Rossum
and
Daan van den Broek
Abstract
Background
New moving average quality control (MA QC) optimization methods have been developed and are available for laboratories. Having these methods will require a strategy to integrate MA QC and routine internal QC.
Methods
MA QC was considered only when the performance of the internal QC was limited. A flowchart was applied to determine, per test, whether MA QC should be considered. Next, MA QC was examined using the MA Generator (www.huvaros.com), and optimized MA QC procedures and corresponding MA validation charts were obtained. When a relevant systematic error was detectable within an average daily run, the MA QC was added to the QC plan. For further implementation of MA QC for continuous QC, MA QC management software was configured based on earlier proposed requirements. Also, protocols for the MA QC alarm work-up were designed to allow the detection of temporary assay failure based on previously described experiences.
Results
Based on the flowchart, 10 chemistry, two immunochemistry and six hematological tests were considered for MA QC. After obtaining optimal MA QC settings and the corresponding MA validation charts, the MA QC of albumin, bicarbonate, calcium, chloride, creatinine, glucose, magnesium, potassium, sodium, total protein, hematocrit, hemoglobin, MCH, MCHC, MCV and platelets were added to the QC plans.
Conclusions
The presented method allows the design and implementation of QC plans integrating MA QC for continuous QC when internal QC has limited performance.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Kazmierczak SC. Laboratory quality control: using patient data to assess analytical performance. Clin Chem Lab Med 2003;41:617–27.10.1515/CCLM.2003.093Search in Google Scholar PubMed
2. Badrick T, Graham P. Can a combination of average of normals and “real time” external quality assurance replace internal quality control? Clin Chem Lab Med 2018;56:549–53.10.1515/cclm-2017-0115Search in Google Scholar PubMed
3. Rosenbaum MW, Flood JG, Melanson SE, Baumann NA, Marzinke MA, Rai AJ, et al. Quality control practices for chemistry and immunochemistry in a cohort of 21 large academic medical centers. Am J Clin Pathol 2018;150:96–104.10.1093/ajcp/aqy033Search in Google Scholar PubMed
4. Parvin CA. Assessing the impact of the frequency of quality control testing on the quality of reported patient results. Clin Chem 2008;54:2049–54.10.1373/clinchem.2008.113639Search in Google Scholar PubMed
5. Yago M, Alcover S. Selecting statistical procedures for quality control planning based on risk management. Clin Chem 2016;62:959–65.10.1373/clinchem.2015.254094Search in Google Scholar PubMed
6. Westgard JO, Bayat H, Westgard SA. Planning risk-based SQC schedules for bracketed operation of continuous production analyzers. Clin Chem 2018;64:289–96.10.1373/clinchem.2017.278291Search in Google Scholar PubMed
7. van Rossum HH. Moving average quality control: principles, practical application and future perspectives. Clin Chem Lab Med 2019;57:773–82.10.1515/cclm-2018-0795Search in Google Scholar PubMed
8. Schoenmakers CH, Naus AJ, Vermeer HJ, van Loon D, Steen G. Practical application of sigma metrics QC procedures in clinical chemistry. Clin Chem Lab Med 2011;49:1837–43.10.1515/cclm.2011.249Search in Google Scholar
9. Fleming JK, Katayev A. Changing the paradigm of laboratory quality control through implementation of real-time testresults monitoring: for patients by patients. Clin Biochem 2015;48:508–13.10.1016/j.clinbiochem.2014.12.016Search in Google Scholar PubMed
10. Ng D, Polito FA, Cervinski MA. Optimization of a moving averages program using a simulated annealing algorithm: the goal is to monitor the process not the patients. Clin Chem 2016;62:1361–71.10.1373/clinchem.2016.257055Search in Google Scholar PubMed
11. Rossum HH, Kemperman H. Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays. Clin Chem Lab Med 2017;55:1142–51.10.1515/cclm-2016-0696Search in Google Scholar PubMed
12. Ye JJ, Ingels SC, Parvin CA. Performance evaluation and planning for patient-based quality control procedures. Am J Clin Pathol 2000;113:240–8.10.1309/V5BT-BAWP-1WBF-14W6Search in Google Scholar PubMed
13. van Rossum HH, Kemperman H. A method for optimization and validation of moving average as continuous analytical quality control instrument demonstrated for creatinine. Clin Chim Acta 2016;457:1–7.10.1016/j.cca.2016.03.008Search in Google Scholar PubMed
14. van Rossum HH, Kemperman H. Optimization and validation of moving average quality control procedures using bias detection curves and moving average validation charts. Clin Chem Lab Med 2017;55:218–24.10.1515/cclm-2016-0270Search in Google Scholar PubMed
15. MA generator. Available at: www.huvaros.com. Accessed: June 2018.Search in Google Scholar
16. Westgard JO. Six sigma quality design and control. Madison, WI: Westgard QC, Inc., 2006:338.Search in Google Scholar
17. Cembrowski GS, Chandler EP, Westgard JO. Assessment of “average of normals” quality control procedures and guidelines for implementation. Am J Clin Pathol 1984;81:492–9.10.1093/ajcp/81.4.492Search in Google Scholar PubMed
18. Desirable Biological Variation Database specifications. Available at: https://www.westgard.com/biodatabase1.htm. Accessed: April 2016.Search in Google Scholar
19. Westgard S, Bayat H, Westgard JO. Analytical sigma metrics: a review of six sigma implementation tools for medical laboratories. Biochem Med (Zagreb) 2018;28: 020502.10.11613/BM.2018.020502Search in Google Scholar PubMed PubMed Central
20. van Rossum HH, Kemperman H. Moving average for continuous quality control: time to move to implementation in daily practice? Clin Chem 2017;63:1041–3.10.1373/clinchem.2016.269258Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Sepsis biomarkers: past, present and future
- Reviews
- Making new biomarkers a reality: the case of serum human epididymis protein 4
- Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
- Opinion Paper
- Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
- EFLM Paper
- Practice in financial support of third party organised conferences and courses at a national level for health care professionals in Europe
- General Clinical Chemistry and Laboratory Medicine
- Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds
- Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
- Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools
- Subcutaneous adipose tissue distribution and telomere length
- Hematology and Coagulation
- Automated measurement of the erythrocyte sedimentation rate: method validation and comparison
- The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants
- Reference Values and Biological Variations
- Narrowed reference intervals for complete blood count in a multiethnic population
- Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures
- Cancer Diagnostics
- Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
- Cardiovascular Diseases
- Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy
- Infectious Diseases
- Evaluation of procalcitonin immunoassay concordance near clinical decision points
- Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients
- Letters to the Editor
- Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
- The short story of the long-term Sigma metric: shift cannot be treated as a linear parameter
- Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI)
- Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review
- Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias
- Inherited bisalbuminemia with growth hormone deficiency
- The first report showing de novo partial 21q monosomy in an adult woman with occult primary ovarian insufficiency (POI)
- Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease
- Practical problems when incorporating rapidly changing microbial taxonomy into clinical practice
- Congress Abstracts
- SGKC/SSCC Annual Assembly 2019 28th-30th August 2019 Technopark, Zurich or Evidence Based Laboratory Medicine
Articles in the same Issue
- Frontmatter
- Editorial
- Sepsis biomarkers: past, present and future
- Reviews
- Making new biomarkers a reality: the case of serum human epididymis protein 4
- Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
- Opinion Paper
- Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
- EFLM Paper
- Practice in financial support of third party organised conferences and courses at a national level for health care professionals in Europe
- General Clinical Chemistry and Laboratory Medicine
- Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds
- Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
- Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools
- Subcutaneous adipose tissue distribution and telomere length
- Hematology and Coagulation
- Automated measurement of the erythrocyte sedimentation rate: method validation and comparison
- The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants
- Reference Values and Biological Variations
- Narrowed reference intervals for complete blood count in a multiethnic population
- Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures
- Cancer Diagnostics
- Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients
- Cardiovascular Diseases
- Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy
- Infectious Diseases
- Evaluation of procalcitonin immunoassay concordance near clinical decision points
- Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients
- Letters to the Editor
- Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
- The short story of the long-term Sigma metric: shift cannot be treated as a linear parameter
- Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI)
- Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review
- Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias
- Inherited bisalbuminemia with growth hormone deficiency
- The first report showing de novo partial 21q monosomy in an adult woman with occult primary ovarian insufficiency (POI)
- Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease
- Practical problems when incorporating rapidly changing microbial taxonomy into clinical practice
- Congress Abstracts
- SGKC/SSCC Annual Assembly 2019 28th-30th August 2019 Technopark, Zurich or Evidence Based Laboratory Medicine
